Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Cancer Res. 2011 Apr 4;71(10):3701–3708. doi: 10.1158/0008-5472.CAN-10-3951

Fig. 6.

Fig. 6

Western blots showing levels of acetyl-H3, E-cadherin, β-catenin and EpCAM after the treatment of HepG2X and HepG2CAT cells with TSA. The blot is representative of three independent experiments.